The 2020 National Alzheimer's Virtual Summit

download
The Summit, held virtually in 2020, will spur collaboration, mobilization and the health system change needed to ensure a brain healthy future for all communities.

Speakers

Micehlle Lujan Grisham headshot
Governor Michelle Lujan Grisham
Democratic Governor
Diane Rehm headshot
Diane Rehm
Executive Producer

Start

October 19, 2020

End

October 21, 2020

Address

Online Event   View map

The National Alzheimer’s Summit will bring together leading policy experts, innovators, researchers, global industry leaders, providers, individuals living with Alzheimer’s, advocates and caregivers – all working towards the shared goal to end Alzheimer’s disease. The Summit, held virtually in 2020, will spur collaboration, mobilization and the health system change needed to ensure a brain healthy future for all communities. This convening will feature engaging town halls sessions with national leaders and experts and will conclude with a night of inspiration during the 7th Annual Trish Vradenburg Be Brain Powerful®.

Registration for the 2020 Virtual Summit is Complimentary. For more information email summit@usagainstalzheimers.org.

2020 Summit Themes

  • Early Intervention: Focusing on strategies for developing proactive brain health across the lifespan by mobilizing communities, consumers, providers and policy makers to transform the healthcare system.
  • Advancing Health Equity and Access: Accelerating equitable access to innovations in brain health for communities of color and women who have faced systemic discrimination and racism when accessing healthcare services and research.
  • Accelerating Treatments and Research: Highlighting innovators across the Alzheimer’s research community, including patient- and caregiver-centered engagement and drug development.
  • Amplifying the Voice of People Living with the Disease: Identifying what matters most to people living with the disease and exploring how these needs and preferences can be prioritized in research, policymaking, and drug development.